RTW INVESTMENTS, LP Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$6.0T
Holdings
102
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (102 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RCKTRocket Pharmaceuticals Inc | 17,060,211 | $935.6B | 15.70% | |
| 2 | IMVTImmunovant Inc | 7,592,253 | $350.7B | 5.88% | |
| 3 | PTCTPTC Therapeutics Inc | 4,221,836 | $257.7B | 4.32% | |
| 4 | MRTXEURMirati Therapeutics Inc | 1,054,364 | $231.6B | 3.89% | |
| 5 | STOKStoke Therapeutics Inc | 3,544,248 | $219.5B | 3.68% | |
| 6 | ALNYAlnylam Pharmaceuticals Inc | 1,681,645 | $218.6B | 3.67% | |
| 7 | NTRANatera Inc | 1,712,234 | $170.4B | 2.86% | |
| 8 | —Dicerna Pharmaceuticals Inc | 7,253,857 | $159.8B | 2.68% | |
| 9 | ARVNArvinas Inc | 1,790,996 | $152.1B | 2.55% | |
| 10 | VCELVericel Corp | 4,517,570 | $139.5B | 2.34% | |
| 11 | AXSMAxsome Therapeutics Inc | 1,672,416 | $136.3B | 2.29% | |
| 12 | ILMNIllumina Inc | 361,778 | $133.9B | 2.25% | |
| 13 | CERNCHFCerner Corp | 1,701,680 | $133.5B | 2.24% | |
| 14 | 3M4Masimo Corp | 469,416 | $126.0B | 2.11% | |
| 15 | GMEDGlobus Med Inc | 1,640,859 | $107.0B | 1.80% | |
| 16 | RNAAvidity Biosciences Inc | 3,995,000 | $102.0B | 1.71% | |
| 17 | TARSTarsus Pharmaceuticals Inc. | 2,463,601 | $99.0B | 1.66% | |
| 18 | AXNX*Axonics Modulation Technolog | 1,883,864 | $94.0B | 1.58% | |
| 19 | DMTKQDermTech Inc | 2,887,215 | $93.7B | 1.57% | |
| 20 | TXG10x Genomics Inc | 660,933 | $93.6B | 1.57% | |
| 21 | —Athira Pharma Inc | 2,685,779 | $88.9B | 1.49% | |
| 22 | ESTAEstablishment Labs Hldgs Inc | 2,319,138 | $87.3B | 1.46% | |
| 23 | —Frequency Therapeutics Inc | 2,461,486 | $86.8B | 1.46% | |
| 24 | ADVMCHFAdverum Biotechnologies Inc | 7,227,364 | $78.3B | 1.31% | |
| 25 | GHGuardant Health Inc | 581,970 | $75.0B | 1.26% | |
| 26 | LUNGPulmonx Corp | 1,129,600 | $74.8B | 1.26% | |
| 27 | PTGXProtagonist Therapeutics Inc | 3,650,069 | $73.6B | 1.23% | |
| 28 | CCCCC4 Therapeutics Inc | 2,149,228 | $68.7B | 1.15% | |
| 29 | TNDMTandem Diabetes Care Inc | 660,982 | $63.2B | 1.06% | |
| 30 | TCE2Celldex Therapeutics Inc New | 3,422,855 | $60.0B | 1.01% | |
| 31 | KURAKura Oncology Inc | 1,701,781 | $55.6B | 0.93% | |
| 32 | —Translate Bio Inc | 2,978,427 | $54.9B | 0.92% | |
| 33 | NSTGEURNanoString Technologies Inc | 804,029 | $53.8B | 0.90% | |
| 34 | CSTLCastle Biosciences Inc | 799,009 | $53.7B | 0.90% | |
| 35 | RLMDRelmada Therapeutics Inc | 1,512,673 | $48.5B | 0.81% | |
| 36 | OPHTEURIVERIC bio Inc | 6,722,624 | $46.5B | 0.78% | |
| 37 | —Five Prime Therapeutics Inc | 2,515,788 | $42.8B | 0.72% | |
| 38 | CYTKCytokinetics Inc | 2,000,000 | $41.3B | 0.69% | |
| 39 | AGENEURAgenus Inc | 12,864,677 | $40.9B | 0.69% | |
| 40 | OYSTOyster Pt Pharma Inc | 1,925,594 | $36.2B | 0.61% | |
| 41 | AVDLAvadel Pharmaceuticals plc | 5,387,513 | $36.0B | 0.60% | |
| 42 | 5E7Iteos Therapeutics Inc | 1,074,166 | $36.0B | 0.60% | |
| 43 | OMGBPOutset Med Inc | 585,074 | $33.3B | 0.56% | |
| 44 | TREURTrillium Therapeutics Inc | 2,165,197 | $31.9B | 0.53% | |
| 45 | PMVPPmv Pharmaceuticals Inc | 500,882 | $30.8B | 0.52% | |
| 46 | —Curis Inc | 3,727,360 | $30.5B | 0.51% | |
| 47 | BLIUSDBerkeley Lts Inc | 324,734 | $29.0B | 0.49% | |
| 48 | MISTMilestone Pharmaceuticals In | 4,315,102 | $28.9B | 0.49% | |
| 49 | MGNXMacroGenics Inc | 1,256,409 | $28.7B | 0.48% | |
| 50 | IDYAIdeaya Biosciences Inc | 1,846,843 | $25.9B | 0.43% | |
| 51 | MDXGMiMedx Group Inc | 2,700,320 | $24.5B | 0.41% | |
| 52 | APYXApyx Medical Corporation | 3,391,279 | $24.4B | 0.41% | |
| 53 | FULCFulcrum Therapeutics Inc | 2,071,409 | $24.3B | 0.41% | |
| 54 | JNJJohnson & Johnson | 149,761 | $23.6B | 0.40% | |
| 55 | I9DNArbutus Biopharma Corp | 5,978,355 | $21.2B | 0.36% | |
| 56 | PRQRProQR Thrapeutics N V | 5,009,768 | $21.0B | 0.35% | |
| 57 | TELATela Bio Inc | 1,383,816 | $20.8B | 0.35% | |
| 58 | PENPenumbra Inc | 118,273 | $20.7B | 0.35% | |
| 59 | —Odonate Therapeutics Inc | 1,000,139 | $19.2B | 0.32% | |
| 60 | XGNExagen Inc | 1,250,131 | $16.5B | 0.28% | |
| 61 | BLUBellus Health Inc New | 5,189,862 | $15.8B | 0.26% | |
| 62 | IMUXImmunic Inc | 920,814 | $14.1B | 0.24% | |
| 63 | AFIBAcutus Med Inc | 451,834 | $13.0B | 0.22% | |
| 64 | RGNXRegenxbio Inc | 282,260 | $12.8B | 0.21% | |
| 65 | —GenMark Diagnostics Inc | 762,994 | $11.1B | 0.19% | |
| 66 | CLSDUSDClearside Biomedical Inc | 3,958,130 | $10.8B | 0.18% | |
| 67 | APVOAptevo Therapeutics Inc | 288,236 | $10.6B | 0.18% | |
| 68 | —Vincera Pharma Inc | 500,000 | $10.5B | 0.18% | |
| 69 | CTMXCytomx Therapeutics Inc | 1,527,352 | $10.0B | 0.17% | |
| 70 | ARGXargenx SE | 31,752 | $9.3B | 0.16% | |
| 71 | —La Jolla Pharmaceutical Co | 2,397,378 | $9.3B | 0.16% | |
| 72 | MLTXHelix Acquisition Corp | 750,000 | $8.5B | 0.14% | |
| 73 | BWAYBrainsway Ltd | 1,103,474 | $8.3B | 0.14% | |
| 74 | CERE1EURCerevel Therapeutics Hldng I | 500,000 | $8.3B | 0.14% | |
| 75 | SRRKScholar Rock Hldg Corp | 166,183 | $8.1B | 0.14% | |
| 76 | —Lifesci Acquisition Ii Corp | 650,000 | $6.9B | 0.12% | |
| 77 | —BCTG Acquisition Corp | 600,000 | $6.9B | 0.12% | |
| 78 | —Bcls Acquisition Corp | 612,500 | $6.8B | 0.11% | |
| 79 | —Therapeutics Acquisition Cor | 490,000 | $6.8B | 0.11% | |
| 80 | INMDInmode Ltd | 124,999 | $5.9B | 0.10% | |
| 81 | —Arya Sciences Acquisition Co | 500,000 | $5.4B | 0.09% | |
| 82 | PSNLPersonalis Inc | 127,501 | $4.7B | 0.08% | |
| 83 | —Itamar Med Ltd | 228,609 | $4.5B | 0.08% | |
| 84 | —5 01 Acquisition Corp | 392,000 | $4.0B | 0.07% | |
| 85 | PHGEBiomx Inc | 600,000 | $3.8B | 0.06% | |
| 86 | —Panacea Acquisition Corp | 300,000 | $3.8B | 0.06% | |
| 87 | IMTXImmatics N.V | 350,000 | $3.8B | 0.06% | |
| 88 | —Chardan Healthcr Acqstn 2 Co | 350,000 | $3.7B | 0.06% | |
| 89 | TWSTTwist Bioscience Corp | 18,473 | $2.6B | 0.04% | |
| 90 | BDSXBiodesix Inc | 125,000 | $2.5B | 0.04% | |
| 91 | PRNProfound Med Corp | 122,098 | $2.5B | 0.04% | |
| 92 | MASS908 Devices Inc | 40,000 | $2.3B | 0.04% | |
| 93 | MRVIMaravai Lifesciences Hldgs I | 70,000 | $2.0B | 0.03% | |
| 94 | EP3OraSure Technologies Inc | 184,000 | $1.9B | 0.03% | |
| 95 | ELUTAziyo Biologics Inc | 125,000 | $1.7B | 0.03% | |
| 96 | —Vincera Pharma Inc | 500,000 | $1.6B | 0.03% | |
| 97 | —Cerevel Therapeutics Hldng I | 166,666 | $942.0M | 0.02% | |
| 98 | BNRBurning Rock Biotech Ltd | 30,000 | $693.0M | 0.01% | |
| 99 | —Progenity Inc | 100,000 | $531.0M | 0.01% | |
| 100 | PHGEBiomX Inc | 600,000 | $480.0M | 0.01% |
Page 1 of 2Next